middle.news
How Echo IQ’s FDA Clearance is Shaping Its US Expansion Strategy
4:19am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Echo IQ’s FDA Clearance is Shaping Its US Expansion Strategy
4:19am on Saturday 30th of August, 2025 AEST
Key Points
Loss after tax widened 145% to $13.26 million
Revenue grew 128% to $101,409
FDA 510(k) clearance obtained for EchoSolv AS
Integration with Beth Israel Deaconess Medical Center completed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Echoiq (ASX:EIQ)
OPEN ARTICLE